Beta
158094

The Safety Profile of Flunixin and its Pharmacological Effects in Chicks

Article

Last updated: 01 Jan 2025

Subjects

-

Tags

Veterinary Parasitology and Bacteriology

Abstract

Background: Flunixin meglumine is a non-steroidal anti-inflammatory drug used in the treatment of several conditions in veterinary medicine. Objective: The study was aimed to investigate the analgesic and anti-inflammatory effects of flunixin meglumine in chicks. Methods: The up and down method was used to assess the median lethal dose (LD50) and effective median analgesic dose (ED50) of flunixin meglumine administered intraperitoneally (i.p.) and orally (p.o.) in chicks. From the obtained values we determined the drug safety indices.  Electric stimulation method was used to determination the dose-dependent analgesic effect of flunixin meglumine in chicks. Analgesic and anti-inflammatory effects were dignified via the formalin test. Results: The median lethal doses (LD50) of flunixin were 143.24mg/kg intraperitoneally and 170.77mg/kg orally. The effective median analgesic doses (ED50) of flunixin meglumine in chicks were 9.34 mg/kg and 11.75 mg/kg for intraperitoneally and orally respectively. The Therapeutic Index, Standard Safety Margin and Therapeutic Ratio of flunixin through intraperitoneal and oral route were (15.35 , 14.53), (0.15 , 0.14) and ( 5.11 , 4.84) respectively.  The dose-dependent analgesic effect of flunixin meglumine at 9 mg/kg, 18 mg/kg ip and 12 mg/kg, 24 mg/kg p.o started at 15 min after treatment and lasted over 120 min of treatment. The analgesic effect peak of flunixin meglumine through intraperitoneal and oral routes was 30 minutes after treatment. In formalin test, flunixin meglumine caused a significant rise in the latency to lift right foot in comparison with the control value, along with a significant decline in foot lifting frequency. A substantial decrease in foot thickness compared to control value has been demonstrated by the anti-inflammatory effects of flunixin meglumine. Conclusion: These results shows that the flunixin has analgesic and anti-inflammatory effects and form the backbone for further pharmacological studies as well as the medication could be safely administered to chicken.

DOI

10.21608/ejvs.2021.65150.1220

Keywords

Flunixin meglumine, LD50, ED50, Formalin test, Analgesia, Drug safety indices, chicks

Authors

First Name

Zahraa

Last Name

Alhumdany

MiddleName

-

Affiliation

Department of physiology, biochemistry, and pharmacology, College of Veterinary Medicine, University of Mosul, Mosul, Iraq

Email

zahraa.m.alhmdany@gmail.com

City

Mosul

Orcid

0000-0002-2615-5751

First Name

Yasser

Last Name

albadrany

MiddleName

-

Affiliation

physiology, biochemistry and pharmacology /college of veterinary medicine/university of Mosul

Email

yasseralbadrany73@gmail.com

City

-

Orcid

0000-0003-4301-1095

Volume

52

Article Issue

2

Related Issue

17188

Issue Date

2021-08-01

Receive Date

2021-02-25

Publish Date

2021-08-01

Page Start

229

Page End

236

Print ISSN

1110-0222

Online ISSN

2357-089X

Link

https://ejvs.journals.ekb.eg/article_158094.html

Detail API

https://ejvs.journals.ekb.eg/service?article_code=158094

Order

11

Type

Original Article

Type Code

140

Publication Type

Journal

Publication Title

Egyptian Journal of Veterinary Sciences

Publication Link

https://ejvs.journals.ekb.eg/

MainTitle

The Safety Profile of Flunixin and its Pharmacological Effects in Chicks

Details

Type

Article

Created At

22 Jan 2023